Probiotics for the management of upper respiratory diseases.
| Autor: | Aragona SE; Center of Regenerative Medicine, Humanitas Mater Domini, Castellanza (VA), Italy., Ciprandi G; Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of biological regulators and homeostatic agents [J Biol Regul Homeost Agents] 2020 Nov-Dec; Vol. 34 (6 Suppl. 1), pp. 1-4. |
| Abstrakt: | Probiotics represent an intriguing challenge in clinical practice. They are currently used worldwide in all fields of Medicine. The present Supplement reports some Italian experiences concerning a probiotic mixture (Abincol®) employed in patients with upper respiratory diseases. A group of Italian otolaryngologists conducted these experiences in a real-world setting. The results demonstrated that this compound might represent a useful therapeutic option in clinical practice. In particularly, this probiotic mixture was tested in patients with rhinosinusitis, pharyngotonsillitis, otitis media, and laryngotracheitis. (Copyright 2020 Biolife Sas. www.biolifesas.org.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|